Project Innovation

[...] , indicating that “85 percent [of those surveyed] were unaware that participation in clinical trials was even an option.” Of those who were aware of clinical trial opportunities available to [...]

[...] To those who are unfamiliar with clinical trials, the process can often seem mysterious and confusing. As summarized by the National [...]

[...] recently connected with cancer survivor Brenda Hawkes, who discussed the importance of clinical trials and the impact on cancer patients. Brenda had a rare form of breast cancer accompanied by a [...]

[...] that Dr. Joan Schiller, oncologist and lung cancer specialist, understands the importance of clinical trials in cancer innovation. By standardizing care to include clinical trial participation, we can [...]

[...] are available. Anne stresses the importance of curating individualized medicines through medical innovation. Many of the current cancer treatment options are what she calls “a one size fits most all [...]

[...] are several ways you can take action this month in working towards improved and hastened medical innovation. Join the Project Innovation movement to help find cancer breakthroughs and treatments. As [...]

[...] from a life-threatening to a chronic disease, we need to move forward with innovation. Medical innovation will shift survival rates and patient quality of life to a place that, as Barry says, “is [...]

[...] , and advocacy group members to discuss how cancer has affected them and the power that medical innovation can provide in cancer treatments and cures. Each voice is equally compelling and important [...]

[...] .[4]  What is more, cancer cases are expected to jump nearly 45 percent by 2030.[5] The Project Innovation mission is simple:  accelerate medical discovery. The time is now to continue seeking new [...]

[...] must make accelerating cancer innovation a priority. We were excited to introduce Project Innovation to this passionate group of advocates at last night’s Patient Congress kick-off dinner, and [...]

[...] Project Innovation spent a busy weekend at the 50th annual meeting of the American Society of Clinical [...]

[...] medicines; they can also provide patients with new hope and a chance at a better prognosis. Project Innovation had the pleasure of speaking with cancer survivor Don Wright while at ASCO 2014 about his [...]

[...] available to them. Clinical trials and the most innovative therapies should be available to cancer patients worldwide. Learn more and join the movement to accelerate innovation in cancer research at [...]

[...] , which ultimately saved his life. Bob noted that following the guide set by HIV patients, cancer patients need to work directly with key stakeholders to ensure their voice is heard. Hear more from [...]

[...] her entire family. She became a patient advocate to fight on behalf of her daughter and all cancer patients to increase medical innovation and save lives. It is crucial to make investments in [...]

[...] Congressional representatives to advocate on this year’s issue: addressing medical debt. Cancer patients, even those who have insurance, too often face significant medical expenses that can lead [...]

[...] each year, resulting in more than 585,000 deaths each year due to cancer. It is time to put cancer innovation on the national agenda, and work towards establishing innovative solutions that will save [...]

[...] member, caregiver, or friend -- to share with us your story about the importance of cancer innovation. We appreciate your willingness to share your personal story with us. Together, we can [...]

[...] at the University of Texas Southwestern Medical Center, is the urgent need to accelerate cancer innovation and speed the delivery of promising new cancer treatments to patients. Relaying the findings [...]

[...] , oncologist and lung cancer specialist, understands the importance of clinical trials in cancer innovation. By standardizing care to include clinical trial participation, we can begin to make larger [...]

[...] conference in San Diego, bringing attention to exciting innovations and discoveries for cancer treatments. Last year's conference welcomed industry leaders from more than 60 countries - offering [...]

[...] progress. Project Innovation has a plan, and offers three solutions to bringing more cancer treatments and cures to children nationwide. As outlined in our white paper, we must do the [...]

[...] notes that the translational period in clinical research is essential; we have to show that cancer treatments work the same way on people that they do in the lab, and we can do this through clinical [...]

[...] patients and take steps towards eliminating cancer as a whole. Join the movement to further cancer treatments and breakthroughs at projectinnovation.org. [...]

[...] moment is equally as important. Susan also discusses the issue of cost when considering cancer treatment. Ask yourself,  what are the monetary costs of my diagnosis? When will I be back in society [...]

[...] was the official introduction of our white paper, Securing the Future of Innovation in Cancer Treatment, to a diverse audience of advocacy organizations, patients, oncologists, and life sciences [...]

[...] benefits that trials yield. In our white paper, Securing the Future of Innovation in Cancer Treatment, we point to the results of a survey of 6,000 cancer patients published by the [...]

[...] cancer affects everyone. As we note in our white paper, Securing the Future of Innovation in Cancer Treatment, more than 1.6 million Americans are diagnosed each year, resulting in more than 585,000 [...]

[...] 33,000 people attended ASCO this year to discuss scientific advances in the field of cancer research, the next generation of medicines, and the value that cancer treatments bring to [...]

[...] to cancer patients worldwide. Learn more and join the movement to accelerate innovation in cancer research at projectinnovation.org. [...]

[...] cancer field who work as research scientists, oncologists, government officials who must fund cancer research, and members of Congress who must appropriate funding for research.  Your story makes the [...]

[...] factors currently affecting the overall process. While Americans are in support of more cancer research, the clinical trial process has become more complicated, time-consuming, and costly [...]

[...] that will get treatments to patients in the safest and quickest ways possible. Clinical research is a complex enterprise, but one in which patients can play a critical role. “Keeping [...]

[...] producing survival rates of years. However, Lori notes that the translational period in clinical research is essential; we have to show that cancer treatments work the same way on people that they [...]

[...] percent of clinical trial enrollment is domestic, and the number of physicians engaging in clinical research has dropped. Clinical trials are essential to the advancement of cancer care,  and we need [...]

[...] below: Most Americans don’t take part in clinical trials Fewer physicians are conducting clinical research The current system is paper-based, slow, and costly Most clinical trials are now conducted [...]

[...] and patients According to recent estimates, only 2-5 percent of adult patients enroll in cancer clinical trials.[5] Rectifying this problem requires improved communication and coordination between [...]

[...] a Clinical Trials Matching Service that works to help patients and their families find cancer clinical trials that are most appropriate to the patient’s medical and personal needs. This service is [...]

To those who are unfamiliar with clinical trials, the process can often seem mysterious and confusing. As summarized by the National Institutes of He [...]